Reports
Sale
Global Assisted Reproductive Technology Market Size, Share: By Procedure: Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor; By Technology: In vitro-fertilization, Artificial Insemination, Others; By Product: Instrument, Accessory & Disposable, Reagent & Media; By Age; By Application; Regional Analysis; Supplier Landscape; 2024-2032
Global Assisted Reproductive Technology Market Size
The global assisted reproductive technology market was valued at USD 29.23 billion in 2023, driven by the increasing infertility rates and rising healthcare expenditure across the globe. The market size is anticipated to grow at a CAGR of 7.24% during the forecast period of 2024-2032 to achieve a value of USD 82.39 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Assisted Reproductive Technology Market Outlook
- The rising infertility rates are impacting the market value as the demand for alternative therapies is increasing.
- One of the significant market trends include rising partnerships and acquisitions amongst key market players. In addition, companies are continuously expanding their product portfolios while leveraging unique and innovative technical advancements. For instance, in June 2023, FUJIFILM Irvine Scientific, Inc., announced the addition of Life Whisperer Genetics module to its Life Whisperer software package, enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF).
- Asia Pacific region is expected to witness substantial market growth in the forecast period. The growth can be attributed to declining population in countries like South Korea and Japan. The well-developed infrastructure and technical advancements in such countries also boosts the demand for assistive reproductive technologies.
Global Assisted Reproductive Technology Market Overview
The increasing advancements in the field by key players are expected to drive the growth of the market in the coming years. The expanding applications of AI in assisted reproductive technology (ART) are expected to further propel the market demand. Advanced technologies, such as precision 3D printing and advanced microscopes, are expected to assist in identifying embryos and promoting healthy pregnancy, further propelling the global assisted reproduction technology market demand.
The rapidly advancing technology is enabling people to conceive even when they are having medical issues. Such advanced technologies are directly contributing to the increasing demand, further fuelling the market growth. A few examples of assisted reproductive technologies include In-vitro Fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), gamete intrafallopian transfer (GIFT), and zygote intrafallopian transfer (ZIFT), among others.
A significant rise in the adoption of these advancing technologies for broader adoption with increasing awareness among healthcare professionals is expected to propel the market growth. The rising cases of infertility worldwide are leading to the increased adoption of assisted reproduction technology (ART), contributing significantly to the assisted reproductive technology market share. The high success rates of ART across the globe are gaining traction while providing hope to people who have some medical issues but look forward to conceiving in the coming future. The increasing disposable income among people mostly in developing countries is also contributing to the market growth.
Global Assisted Reproductive Technology Market Growth Drivers
Technological Advancements Bolstering the Market
The key players in the market are focusing on developing advanced healthcare systems to assist people in need of assisted reproduction technology, which is further expected to greatly influence the assisted reproduction technology market demand. Technologies like machine learning models are being introduced in the market to optimize hormonal treatments, including FSH (follicle-stimulating hormone) for better results. Other than that, various innovative platforms have been working on enabling remote monitoring and testing, various efforts are being made in electronic witnessing systems and robotic cryopreservation systems, which can help streamline the whole system of tracking and preserving eggs, sperms, and embryos. AI tools are one of the biggest developments in the healthcare sector, these tools are widely being used to enhance the fertility outcomes and make it more cost-effective.
For instance, in October 2022, Alife, after doing thorough research and development for over two years, introduced a new AI based software that can aid fertility clinics to improve fertility outcomes by optimizing and supporting the critical decisions during the process of IVF.
Rising Support from the Government to Support the Growth of the Assisted Reproductive Technology Market
The growth of the market is driven by the increasing initiatives by governments towards the regulation of practices as safe and effective for the people acquiring assistance from such services. For instance, In April 2023, the Ministry of Health and Family Welfare (MoHFW) rolled back the manner of retrieving oocytes and placing embryos vide assisted reproductive technology regulations in a manner where the health of the patient would not be compromised.
Additionally, In June 2023, the government of Beijing announced that they will cover 16 types of assisted reproduction technology under the city's health care system. This is an effort to boost China's declining birth rate. In-vitro fertilization, embryo transplantation, freezing, and storing semen are some of the treatments that will be included under basic insurance. This initiative by the government is expected to drive the market growth by encouraging people to have babies. The expenses of these services will be covered under health insurance, making it more convenient for people to avail of the services. This change is expected to increase the adaptation and demand for these services in the market during the forecast period. It could potentially lead to more people using these methods to have babies, which in turn could increase the number of births in Beijing.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Assisted Reproductive Technology Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Key Trends | Impact |
| Rising Prevalence of Infertility | The growth of the market is primarily driven by the rising prevalence of infertility and other reproductive issues across the world. Infertility affects millions of people every year, one in every six people of reproductive age, which is nearly 17.5% of the total adult population, is affected by infertility in their life. Assisted reproductive technologies have been in the market for over three decades and have intervened in the birth of more than 5 million children across the world. These technologies are still widely inaccessible because of the price point, which is unaffordable for majority of the population, especially in low-income countries. |
| Global Recognition by Regulatory Authorities | The market is witnessing surge in approvals from regulatory authorities to promote the innovative and new technologies in the market. In April 2023, TMRW Life Sciences, a fertility technology company automating the IVF lab, announced the receiving of CE Mark for the CryoRobot Select (CRS). The European designation follows clearance by the U.S. Food and Drug Administration, and the two regulatory achievements demonstrate that TMRW's automated platform for the safe management and storage of frozen eggs and embryos is now the global standard. TMRW’s recognition as a global standard is expected to increase the widespread adaptation of this technology to make the whole process safer and more standardized. |
| Strategic Acquisition Activities by Key Players | The rising competition amongst the key players is also aiding the assisted reproductive technology market growth. In July 2023, Baring Private Equity Asia (BPEA) EQT agreed to acquire a controlling stake in Indira IVF from TA Associates and the company’s founders. BPEA EQT is expected to acquire a 60% stake for USD 656.6 million. As India is one of the fastest-growing markets globally for assisted reproductive technology services, this acquisition is further anticipated to increase the market reach in more developed markets with this acquisition, driving the market growth. |
| Expanding Applications | Increased application of assisted reproductive technologies in emerging domains such as surrogacy is amongst major market trends. Traditionally, surrogacy used to rely on surrogate mother's egg for conception. However, currently, there is a preference for transferring embryos to the surrogate, either from the mother or donor. This is leading to adoption of assisted reproductive technologies across multiple domains. |
Recent Developments in the Global Assisted Reproductive Technology Market
In March 2024, the Australian government announced a USD 42.3 million investment to launch multiple programs intended to boost fertility in the region. It is reported that 1 in 6 Australians are facing fertility associated challenges, pushing the demand for assisted reproductive technologies. Under the new investment plan, around USD 32.1 million is expected to offer subsidized reproductive assistance treatment while USD 10.2 million will be directed towards a statewide "fertility preservation service", educating people to make family planning decisions effectively. The initiative is also focused on providing affordable ART to both males and females.
In June 2023, FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package, enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF). Life Whisperer Genetics, when combined with Life Whisperer Viability, offers a distinctive way to help choose blastocysts during clinical processes. This combined platform helps identify blastocysts with a higher chance of being euploid and leading to successful pregnancies, all within a single system.
Global Assisted Reproductive Technology Market Segmentation
Market Breakup by Procedure
- Fresh Donor
- Fresh Non-donor
- Frozen Donor
- Frozen Non-donor
Market Breakup by Technology
- In vitro-fertilization
- Artificial Insemination
- Others
Market Breakup by Product
- Instrument
- Accessory & Disposable
- Reagent & Media
Market Breakup by Age
- Women Younger Than Age 35
- Women Older Than Age 35
Market Breakup by Application
- Frozen Embryo Replacement (FER)
- Surrogacy
- Ovulation Induction
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Assisted Reproductive Technology Market Share
Market Segmentation Based on Technique is Anticipated to Witness Substantial Growth
Based on technique, the market is segmented into in vitro-fertilization, artificial insemination, and others. In-vitro fertilization is expected to hold a substantial market share in the forecast period. The market value for this segment can be attributed to high success rates, advantages such as preimplantation genetic testing (PGT), allowing embryo screening for genetic disorders. Artificial insemination is likely to gain significant growth, owing to its less invasive nature and a simpler process as compared to in-vitro fertilization.
Application Areas to Experience Notable Growth in Forecast Period
The market segmentation based on application includes frozen embryo replacement (FER), surrogacy, ovulation induction, and others. These application address different aspects and needs of patients, catering to specific medical conditions and history of a patient. Frozen embryo replacement (FER) includes embryo freezing, thawing, and transferring to a uterus. With minimal physical and emotional burden, it helps in higher success rate, convenience, and improved outcomes for patients. Surrogacy has also emerged as a functional application area, with shifts from traditional methods (where the mother was artificially inseminated) to gestational surrogacies, which facilitate gamete implantation with no genetic connection. In addition, ovulation induction requires assisted reproductive technologies, as it includes the use of medicines to stimulate ovaries for egg production and release.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Global Assisted Reproductive Technology Market Analysis by Region
North America has been leading the global market for assisted reproductive technology and it is likely to continue dominating the market in the forecast period. The region is anticipated to dominate in the forecast period due to the robust healthcare infrastructure and decreasing fertility, increasing research activities. The region is likely to continue dominating the global market owing to the presence of renowned clinics in the region.
In October 2023, Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies ("ART") research and cell biology markets, announced that they have acquired Gynetics Medical Products, N.V., and Gynetics Services B.V. (collectively, "Gynetics"). Gynetics, based in Lommel, Belgium is a leading manufacturer of a wide range of innovative, high-quality In Vitro Fertilization ("IVF") devices in the global IVF market. The acquisition is poised to highlight Hamilton Thorne's consumables product offerings and increase the market reach for profitable operations in the well-established European ART market.
Leading Players in the Global Assisted Reproductive Technology Market
The key features of the market report comprise patent analysis, clinical trial analysis, and strategic initiatives by the leading players including mergers and collaborations and new product launches. The major companies in the market are as follows:
California Cryobank
California Cryobank based out of United States, has a significant market presence. It offers multiple services and programs leveraging assisted reproductive technology. Major services include donor semen programs, genetic services and CCB family services, among others.
Merck KGaA
Headquartered in Germany, Merck KGaA, with key areas of attention such as ovarian stimulation, luteal phase support, embryo culture and handling, cryopreservation along with diagnostic tools. It is a pioneer in research and focuses on developing novel therapeutic approaches.
FUJIFILM Irvine Scientific
California-based, FUJIFILM Irvine Scientific was established in 1970. It is known for high quality IVF culture media, offering a nurturing environment to embryos. Moreover, the company is constantly expanding its services focused on personalised medicine approaches, and methods to improve implantation rates.
Nikon Corporation
Established in 1917, it is a well-known organisation with expertise in imaging equipment and provides high-quality microscopes and imaging systems vital for several ART procedures. The company is focusing on integrating AI and digital technologies to offer accurate diagnosis of embryo and gametes.
Other key players in the market include Bloom Fertility Centre, Anecova, CooperSurgical, Ferring B.V., Genea Pty Ltd., Nidacon International AB, Celmatix Inc., Microm U.K. Ltd., Cryolab Ltd., and Vitrolife AB.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Procedure |
|
| Breakup by Technology |
|
| Breakup by Product |
|
| Breakup by Age |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Global Assisted Reproductive Technology Market Report
- What was the global assisted reproductive technology market value in 2023?
- What is the global assisted reproductive technology market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on product?
- What is the market breakup based on procedure?
- What is the market segmentation based on technology?
- What are the major application areas of assisted reproductive technology?
- What is the market breakup based on age?
- What are the major factors aiding the global assisted reproductive technology market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints?
- Which age bracket is expected to require high demand of assisted reproductive technology in the forecast period?
- What lifestyle factors boost the demand for assisted reproductive technology?
- Which procedure is expected to witness significant demand in the coming years?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to witness expedited growth during the forecast period?
- How does the prevalence and incidence of genetic disorders affect the market landscape?
- What are the major global assisted reproductive technology market trends?
- What product will dominate the market share?
- Which technique is expected to have a high market value in the coming years?
- Which application area is projected to contribute to the highest market growth?
- Who are the key players involved in the assisted reproductive technology market?
- What are the current unmet needs and challenges in the market?
- What are the latest government initiatives that are expected to boost the market value for assisted reproductive technologies?
- How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Assisted Reproductive Technology Market Overview
3.1 Global Assisted Reproductive Technology Market Historical Value (2017-2023)
3.2 Global Assisted Reproductive Technology Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Assisted Reproductive Technology Market Landscape*
5.1 Global Assisted Reproductive Technology: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Assisted Reproductive Technology: Product Landscape
5.2.1 Analysis by Procedure
5.2.2 Analysis by Technology
5.2.3 Analysis by Product
5.2.4 Analysis by Application
5.2.5 Analysis by Age
6 Global Assisted Reproductive Technology Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Assisted Reproductive Technology Market Segmentation (2017-2032)
7.1 Global Assisted Reproductive Technology Market (2017-2032) by Procedure
7.1.1 Market Overview
7.1.2 Fresh Donor
7.1.3 Fresh Non-donor
7.1.4 Frozen Donor
7.1.5 Frozen Non-donor
7.2 Global Assisted Reproductive Technology Market (2017-2032) by Technology
7.2.1 Market Overview
7.2.2 In vitro-fertilization
7.2.3 Artificial Insemination
7.2.4 Others
7.3 Global Assisted Reproductive Technology Market (2017-2032) by Product
7.3.1 Market Overview
7.3.2 Instrument
7.3.3 Accessory & Disposable
7.3.4 Reagent & Media
7.4 Global Assisted Reproductive Technology Market (2017-2032) by Age
7.4.1 Market Overview
7.4.2 Women Younger Than Age 35
7.4.3 Women Older Than Age 35
7.5 Global Assisted Reproductive Technology Market (2017-2032) by Application
7.5.1 Market Overview
7.5.2 Frozen Embryo Replacement (FER)
7.5.3 Surrogacy
7.5.4 Ovulation Induction
7.5.5 Others
7.6 Global Assisted Reproductive Technology Market (2017-2032) by Region
7.6.1 Market Overview
7.6.2 North America
7.6.3 Europe
7.6.4 Asia Pacific
7.6.5 Latin America
7.6.6 Middle East and Africa
8 North America Assisted Reproductive Technology Market (2017-2032)
8.1 North America Assisted Reproductive Technology Market (2017-2032) by Procedure
8.1.1 Market Overview
8.1.2 Fresh Donor
8.1.3 Fresh Non-donor
8.1.4 Frozen Donor
8.1.5 Frozen Non-donor
8.2 North America Assisted Reproductive Technology Market (2017-2032) by Technology
8.2.1 Market Overview
8.2.2 In vitro-fertilization
8.2.3 Artificial Insemination
8.2.4 Others
8.3 North America Assisted Reproductive Technology Market (2017-2032) by Product
8.3.1 Market Overview
8.3.2 Instrument
8.3.3 Accessory & Disposable
8.3.4 Reagent & Media
8.4 North America Assisted Reproductive Technology Market (2017-2032) by Age
8.4.1 Market Overview
8.4.2 Women Younger Than Age 35
8.4.3 Women Older Than Age 35
8.5 North America Assisted Reproductive Technology Market (2017-2032) by Application
8.5.1 Market Overview
8.5.2 Frozen Embryo Replacement (FER)
8.5.3 Surrogacy
8.5.4 Ovulation Induction
8.5.5 Others
8.6 North America Assisted Reproductive Technology Market (2017-2032) by Country
8.6.1 United States of America
8.6.2 Canada
9 Europe Assisted Reproductive Technology Market (2017-2032)
9.1 Europe Assisted Reproductive Technology Market (2017-2032) by Procedure
9.1.1 Market Overview
9.1.2 Fresh Donor
9.1.3 Fresh Non-donor
9.1.4 Frozen Donor
9.1.5 Frozen Non-donor
9.2 Europe Assisted Reproductive Technology Market (2017-2032) by Technology
9.2.1 Market Overview
9.2.2 In vitro-fertilization
9.2.3 Artificial Insemination
9.2.4 Others
9.3 Europe Assisted Reproductive Technology Market (2017-2032) by Product
9.3.1 Market Overview
9.3.2 Instrument
9.3.3 Accessory & Disposable
9.3.4 Reagent & Media
9.4 Europe Assisted Reproductive Technology Market (2017-2032) by Age
9.4.1 Market Overview
9.4.2 Women Younger Than Age 35
9.4.3 Women Older Than Age 35
9.5 Europe Assisted Reproductive Technology Market (2017-2032) by Application
9.5.1 Market Overview
9.5.2 Frozen Embryo Replacement (FER)
9.5.3 Surrogacy
9.5.4 Ovulation Induction
9.5.5 Others
9.6 Europe Assisted Reproductive Technology Market (2017-2032) by Country
9.6.1 United Kingdom
9.6.2 Germany
9.6.3 France
9.6.4 Italy
9.6.5 Others
10 Asia Pacific Assisted Reproductive Technology Market (2017-2032)
10.1 Asia Pacific Assisted Reproductive Technology Market (2017-2032) by Procedure
10.1.1 Market Overview
10.1.2 Fresh Donor
10.1.3 Fresh Non-donor
10.1.4 Frozen Donor
10.1.5 Frozen Non-donor
10.2 Asia Pacific Assisted Reproductive Technology Market (2017-2032) by Technology
10.2.1 Market Overview
10.2.2 In vitro-fertilization
10.2.3 Artificial Insemination
10.2.4 Others
10.3 Asia Pacific Assisted Reproductive Technology Market (2017-2032) by Product
10.3.1 Market Overview
10.3.2 Instrument
10.3.3 Accessory & Disposable
10.3.4 Reagent & Media
10.4 Asia Pacific Assisted Reproductive Technology Market (2017-2032) by Age
10.4.1 Market Overview
10.4.2 Women Younger Than Age 35
10.4.3 Women Older Than Age 35
10.5 Asia Pacific Assisted Reproductive Technology Market (2017-2032) by Application
10.5.1 Market Overview
10.5.2 Frozen Embryo Replacement (FER)
10.5.3 Surrogacy
10.5.4 Ovulation Induction
10.5.5 Others
10.6 Asia Pacific Assisted Reproductive Technology Market (2017-2032) by Country
10.6.1 China
10.6.2 Japan
10.6.3 India
10.6.4 ASEAN
10.6.5 Australia
10.6.6 Others
11 Latin America Assisted Reproductive Technology Market (2017-2032)
11.1 Latin America Assisted Reproductive Technology Market (2017-2032) by Procedure
11.1.1 Market Overview
11.1.2 Fresh Donor
11.1.3 Fresh Non-donor
11.1.4 Frozen Donor
11.1.5 Frozen Non-donor
11.2 Latin America Assisted Reproductive Technology Market (2017-2032) by Technology
11.2.1 Market Overview
11.2.2 In vitro-fertilization
11.2.3 Artificial Insemination
11.2.4 Others
11.3 Latin America Assisted Reproductive Technology Market (2017-2032) by Product
11.3.1 Market Overview
11.3.2 Instrument
11.3.3 Accessory & Disposable
11.3.4 Reagent & Media
11.4 Latin America Assisted Reproductive Technology Market (2017-2032) by Age
11.4.1 Market Overview
11.4.2 Women Younger Than Age 35
11.4.3 Women Older Than Age 35
11.5 Latin America Assisted Reproductive Technology Market (2017-2032) by Application
11.5.1 Market Overview
11.5.2 Frozen Embryo Replacement (FER)
11.5.3 Surrogacy
11.5.4 Ovulation Induction
11.5.5 Others
11.6 Latin America Assisted Reproductive Technology Market (2017-2032) by Country
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Mexico
11.6.4 Others
12 Middle East and Africa Assisted Reproductive Technology Market (2017-2032)
12.1 Middle East and Africa Assisted Reproductive Technology Market (2017-2032) by Procedure
12.1.1 Market Overview
12.1.2 Fresh Donor
12.1.3 Fresh Non-donor
12.1.4 Frozen Donor
12.1.5 Frozen Non-donor
12.2 Middle East and Africa Assisted Reproductive Technology Market (2017-2032) by Technology
12.2.1 Market Overview
12.2.2 In vitro-fertilization
12.2.3 Artificial Insemination
12.2.4 Others
12.3 Middle East and Africa Assisted Reproductive Technology Market (2017-2032) by Product
12.3.1 Market Overview
12.3.2 Instrument
12.3.3 Accessory & Disposable
12.3.4 Reagent & Media
12.4 Middle East and Africa Assisted Reproductive Technology Market (2017-2032) by Age
12.4.1 Market Overview
12.4.2 Women Younger Than Age 35
12.4.3 Women Older Than Age 35
12.5 Middle East and Africa Assisted Reproductive Technology Market (2017-2032) by Application
12.5.1 Market Overview
12.5.2 Frozen Embryo Replacement (FER)
12.5.3 Surrogacy
12.5.4 Ovulation Induction
12.5.5 Others
12.6 Middle East and Africa Assisted Reproductive Technology Market (2017-2032) by Country
12.6.1 Saudi Arabia
12.6.2 United Arab Emirates
12.6.3 Nigeria
12.6.4 South Africa
12.6.5 Others
13 Regulatory Framework
13.1 Regulatory Overview
13.2 US FDA
13.3 EU EMA
13.4 INDIA CDSCO
13.5 JAPAN PMDA
13.6 Others
14 Patent Analysis
14.1 Analysis by Type of Patent
14.2 Analysis by Publication Year
14.3 Analysis by Issuing Authority
14.4 Analysis by Patent Age
14.5 Analysis by CPC Analysis
14.6 Analysis by Patent Valuation
14.7 Analysis by Key Players
15 Clinical Trial Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 California Cryobank
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Bloom Fertility Centre
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Anecova
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 CooperSurgical
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Merck KGaA
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Ferring B.V .
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 FUJIFILM Irvine Scientific
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Genea Pty Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Nidacon International AB
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Celmatix Inc .
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Microm U.K. Ltd .
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Cryolab Ltd .
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Vitrolife AB
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Nikon corporation
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Assisted Reproductive Technology Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER